Skip to content

A Multi Center Study Comparing the Efficacy of CAD EYE and the Standard of Care (White Light )

A Multi-center Control Study to Determine the Efficacy of CADEYE in Detecting Colon Polyps in Comparison to Standard of Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05523271
Enrollment
1000
Registered
2022-08-31
Start date
2023-01-16
Completion date
2023-08-30
Last updated
2023-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer screening

Brief summary

This study is to assess the sensitivity and added benefits of CADEYE compared to standard care (white-light) in detecting colon polyps in patients undergoing colonoscopy.

Detailed description

Failure in polyp recognition is a major determinant for the high rate of missed colorectal neoplasms. In response, technological advances have paved the way for Computer-Aided Polyp Detection (CAD-e) systems. Artificial intelligence systems allow of real-time computer- aided detection of polyps with high-accuracy. CADEYE is a CAD-e system (FUJIFILM) that enables real-time video processing at the same rate as the standard procedure. The data generated from this study will provide an estimate of the ADR throughout the Middle East as well as assess the accuracy of CADEYE in detecting adenomas in comparison to standard of care.

Interventions

DIAGNOSTIC_TESTCAD EYE (Computer Aided Diagnosis ----?

CADEYE is a CAD-e system (FUJIFILM) that enables real-time video processing at the same rate as the standard procedure and and allows a real time computer aided detection of polyps with high accuracy.

Sponsors

Theodor Bilharz Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 40-80 years old subjects * Subjects undergoing colonoscopy for the following: o Primary CRC screening * Post-polypectomy surveillance * Work up following FIT positivity * Symptoms/signs suspicions of CRC * Subjects must be willing to give written informed consent for the trial

Exclusion criteria

* Unable to consent * Contraindicated to undergo endoscopy * Hospitalized patient * Patients with the following conditions: * History of colon resection * History of CRC * Antithrombotic therapy precluding colon resection o Inflammatory Bowel Disease (IBD) * Familial Adenomatous Polyposis (FAP) * Pregnant or lactating * Poor bowel preparation: BBPS 0 or 1 in a segment

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate1 yearAdenoma detection rate is the primary end point which is the percentage of patients with at least 1 histologically proven adenoma or carcinoma.

Secondary

MeasureTime frame
Adenomas detected per colonoscopy1 year
Proximal Adenoma detection rate1 year
Withdrawal time1 year
Non-neoplastic detection rate1 year

Countries

Egypt

Contacts

Primary ContactMostafa Ibrahim, M.D PhD
mostafa.ibrahim@webgit.net01006107100
Backup ContactFarah Ebrahim, Medicine
Farah.Ahmed@roeyaegypt.com01066443936

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026